After the stock price fell by the limit, international medicine burst into an even bigger thunder.
Last night, the international medical announcement, after the study of the Xi'an Health Committee, closed the two hospitals for three months and reopened the clinic after the expiration of the rectification period. According to the regulations, the matter triggered the corresponding situation in which "other risk warnings were implemented on the stocks of listed companies". The company's shares have been suspended for one day since the opening of the market on January 14 and resumed trading since the opening of the market on January 17. Other risk warnings have been implemented since the opening of the company's stock on January 17, and the abbreviation of the company's stock has been changed from "International Medicine" to "ST National Medicine".
After the current round of epidemic in Xi'an, due to the mechanical implementation of relevant epidemic prevention policies in front of the company's high-tech hospitals and central hospitals, the rescue and diagnosis and treatment of critically ill patients were delayed, causing widespread public concern, resulting in serious consequences. After the study of Xi'an Health Committee, the two hospitals were closed for rectification for 3 months and reopened after the expiration of the rectification period.
According to Article 9.8.1 of the rules governing the listing of stocks on the Shenzhen Stock Exchange (revised in 2022), this matter triggers the corresponding situation in which "other risk warnings are implemented on the stocks of listed companies".
The phenomenon of international medicine being ST due to other abnormal conditions is rare in A-share history, and there have been other risk warnings for immortal organisms due to the "vaccine gate" incident before.
Prior to the incident of fetal abortion involving pregnant women in Xi'an, it caused an uproar in the society, and Xi'an High-tech Hospital, a hospital under international medicine, has also become the focus of attention.
This morning, Xi'an Municipal Health Committee issued a notice saying that after this round of epidemic, Xi'an High-tech Hospital and Xi'an International Medical Center Hospital failed to implement the "people first, life first" in the medical treatment work. The sense of responsibility is weak, failed to perform the duty of saving lives, failed to implement the core system of medical quality management, such as first diagnosis responsibility and emergency and critical patients rescue. It leads to delay in the rescue and diagnosis of critically ill patients, which leads to widespread public concern and bad social impact. According to the study, Xi'an High-tech Hospital and Xi'an International Medical Center Hospital will be closed for rectification for three months from now, and the clinic will be reopened after the rectification and reform has expired.
It is worth noting that international medical shares opened sharply lower than 8% this morning, and finally sealed the falling limit after a shock rebound. As of the close, there are still 730000 orders firmly sealed by the limit.
After-market data show that among the seller's seats, four institutional seats have been sold for a total of 201 million yuan.
According to the data of the International Medical Triennial Bulletin, as of September 30, 2021, the number of shareholders of the company was 144800. Just after the limit fell, the news of being ST came out again in the evening. 140000 shareholders may be directly confused.
According to the official website, Xi'an High-tech Hospital was established on June 9, 2002. it is a joint-stock general hospital integrating medical treatment, teaching, scientific research, prevention and health care. It was approved as China's first socially run Grade 3A hospital in 2009 and successfully passed the top three review in June 2017.
It is worth mentioning that Xi'an High-tech Hospital is one of the important subsidiaries of international medicine. According to the data, Xi'an High-tech Hospital Co., Ltd. achieved an income of 798 million yuan and a net profit of 60.6681 million yuan in 2020, while the revenue of international medicine in the same period was 1.607 billion yuan, and the net profit of returning mother was 45.3605 million yuan. Xi'an High-tech Hospital has become the most profitable subsidiary of international medicine.
In addition, in the first half of 2021, the total number of outpatients and emergency departments in Xi'an High-tech Hospital exceeded 650000, an increase of 70.75 percent over the same period last year, the number of inpatients exceeded 24000, an increase of 55.08 percent over the same period last year, and the number of operations exceeded 6700, an increase of 53.90 percent over the same period last year. Revenue reached 538 million yuan, accounting for more than 40% of the company's total revenue of 1.306 billion yuan in the first half of the year.